FILE - A pharmacist holds a vial of lenacapavir, an injectable HIV prevention drug, at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, ...

Generics of Gilead Sciences' twice-yearly HIV pre-exposure prophylaxis (PrEP) Yeztugo (lenacapavir) are on the horizon, with India's Dr. Reddy’s Laboratories and Hetero Labs striking separate ...

U.S. Indication for Yeztugo Yeztugo (lenacapavir) injection, 463.5 mg/1.5 mL, is indicated for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents ...

More common side effects of Yeztugo include injection site reactions, headache, and nausea. Yeztugo has a boxed warning about the risk of drug resistance when used in people with undiagnosed HIV. If ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more than ...

When Gilead Sciences rolled out its first sales projections for twice-yearly pre-exposure prophylaxis (PrEP) med Yeztugo (lenacapivir) at the start of this year, analysts dubbed the company’s $800 ...

Lenacapavir 463.5mg/1.5mL (309mg/mL); soln for SC inj; preservative-free. Lenacapavir is a multistage, selective inhibitor of HIV-1 capsid function that directly binds to the interface between capsid ...

How Does Yeztugo Work to Prevent HIV? HIV is a virus that has a coating around it, which is called a capsid. In order for HIV to make copies of itself and spread within your body, it needs to get ...

Yeztugo (lenacapavir) is a prescription drug approved to help prevent HIV. Yeztugo comes as a long-acting injection and an oral tablet. Specifically, Yeztugo is prescribed as preexposure prophylaxis ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® (lenacapavir)—the company’s ...